Plant-Derived Products with Therapeutic Potential against Gastrointestinal Bacteria
Pathogens · 15.02.2023 · 12 (2) · 333
DOI: 10.3390/pathogens12020333 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathogens, online erschienen am 15.02.2023. Verfasst von Fatimah I Qassadi und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, UK. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 186 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Saudi Ministry of Higher Education.
Abstract (Originalsprache)
The rising burden of antimicrobial resistance and increasing infectious disease outbreaks, including the recent COVID-19 pandemic, has led to a growing demand for the development of natural products as a valuable source of leading medicinal compounds. There is a wide variety of active constituents found in plants, making them an excellent source of antimicrobial agents with therapeutic potential as alternatives or potentiators of antibiotics. The structural diversity of phytochemicals enables them to act through a variety of mechanisms, targeting multiple biochemical pathways, in contrast to traditional antimicrobials. Moreover, the bioactivity of the herbal extracts can be explained by various metabolites working in synergism, where hundreds to thousands of metabolites make up the extract. Although a vast amount of literature is available regarding the use of these herbal extracts against bacterial and viral infections, critical assessments of their quality are lacking. This review aims to explore the efficacy and antimicrobial effects of herbal extracts against clinically relevant gastrointestinal infections including pathogenic Escherichia coli, toxigenic Clostridioides difficile, Campylobacter and Salmonella species. The review will discuss research gaps and propose future approaches to the translational development of plant-derived products for drug discovery purposes for the treatment and prevention of gastrointestinal infectious diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, UK.
- Department of Pharmacognosy, College of Pharmacy, Prince Sattam bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.
- NIHR Nottingham Biomedical Research Centre, University of Nottingham, Nottingham NG7 2RD, UK.
- Nottingham Digestive Diseases Centre, School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK.
ORCID-Profile: Fatimah I Qassadi, Zheying Zhu, Tanya M Monaghan
Förderung
- Saudi Ministry of Higher Education
Zitieren
APA
Qassadi, F. I., Zhu, Z., & Monaghan, T. M. (2023). Plant-Derived Products with Therapeutic Potential against Gastrointestinal Bacteria. Pathogens, 12(2), 333. https://doi.org/10.3390/pathogens12020333
Vancouver
Qassadi FI, Zhu Z, Monaghan TM. Plant-Derived Products with Therapeutic Potential against Gastrointestinal Bacteria. Pathogens. 2023;12(2):333. doi:10.3390/pathogens12020333
BibTeX
@article{Qassadi2023,
author = {Qassadi, Fatimah I and Zhu, Zheying and Monaghan, Tanya M},
title = {Plant-Derived Products with Therapeutic Potential against Gastrointestinal Bacteria},
journal = {Pathogens},
year = {2023},
volume = {12},
number = {2},
pages = {333},
doi = {10.3390/pathogens12020333}
}
EUVIMED